Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis
Top Cited Papers
- 1 February 2009
- journal article
- review article
- Published by Elsevier in The Lancet
- Vol. 373 (9665) , 746-758
- https://doi.org/10.1016/s0140-6736(09)60046-5
Abstract
No abstract availableKeywords
This publication has 120 references indexed in Scilit:
- Initial Severity and Antidepressant Benefits: A Meta-Analysis of Data Submitted to the Food and Drug AdministrationPLoS Medicine, 2008
- Selective Publication of Antidepressant Trials and Its Influence on Apparent EfficacyNew England Journal of Medicine, 2008
- A comparative study of the efficacy of acute and continuation treatment with escitalopram versus duloxetine in patients with major depressive disorderCurrent Medical Research and Opinion, 2007
- Early Onset of Selective Serotonin Reuptake Inhibitor Antidepressant ActionArchives of General Psychiatry, 2006
- A randomized, double-blind, 24‐week study of escitalopram (10 mg/day) versus citalopram (20 mg/day) in primary care patients with major depressive disorderCurrent Medical Research and Opinion, 2005
- Efficacy and tolerability of venlafaxine in geriatric outpatients with major depression: a double‐blind, randomised 6‐month comparative trial with citalopramInternational Journal of Geriatric Psychiatry, 2004
- Measuring inconsistency in meta-analysesBMJ, 2003
- Efficacy and tolerability of citalopram in comparison with fluvoxamine in depressed outpatientsInternational Clinical Psychopharmacology, 1996
- A Double-Blind, Randomized, Fluoxetine-Controlled, Multicenter Study of Paroxetine in the Treatment of DepressionJournal of Clinical Psychopharmacology, 1993
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986